RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies designed to modulate the immune system. Leveraging our proprietary products, robust clinical development expertise, and cutting-edge-manufacturing capabilities, we advance two potentially groundbreaking programs, umbilical cord lining stem cells (ULSCs) for auto-immune diseases and natural killer cell (NK) therapeutics targeting senescence and age-associated disorders. Our therapies are intended to treat a broad range of disabling diseases and are designed to improve patient outcomes, as well as overall health and wellness. RESTEM is headquartered in Miami, Florida.
Company Details
- Employees
- 18
- Founded
- -
- Address
- 1728 Coral Way,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://restem.com/
- Keywords
- Technician jobs.
- HQ
- Miami, Florida
Restem Questions
Restem's website is https://restem.com/
Restem's LinkedIn profile is https://www.linkedin.com/company/restemgroup
Restem has
18 employees.
View email and phone details for 18
employees at Restem.
Restem's industry is
Biotechnology Research
Restem's top competitors are
Rain Oncology,
Gentera Center For Precision Medicine,
Optimal Balance Pharmacy,
Liveyon Llc,
Juvexo,
Exir Bio,
Targazyme,
Biobox Analytics,
Orgagen Biosciences,
The Biobox, Llc.
Restem's categories are Biotechnology Research
Restem's founding year is 2016
